サインイン

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.

The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled back to methionine through a process referred to as remethylation.

Methylated products exhibit distinct characteristics. They are generally irreversible, highly polar, and water-soluble metabolites. While often less pharmacologically active than their parent drug due to decreased affinity for target receptors or enzymes, methylation can enhance or retain a drug's activity in some instances.

Several functional groups, including hydroxyl, amino, thiol, and carboxyl, can undergo methylation. A notable example is the drug codeine, which morphs into a more potent analgesic, morphine, via methylation. Similarly, the neurotransmitter dopamine can be methylated to produce epinephrine, a hormone that plays a pivotal role in the body's stress response.

To sum up, methylation is a significant biotransformation reaction integral to drug detoxification and elimination from the body. It transforms lipophilic drugs into polar metabolites that are readily excreted. Catalyzed by methyltransferase enzymes, methylation impacts various functional groups, resulting in altered pharmacological activity of the products.

タグ

MethylationPhase II ReactionsBiotransformationMethyltransferasesS adenosylmethionine SAMS adenosylhomocysteine SAHHomocysteineRemethylationMetabolitesDrug DetoxificationPharmacological ActivityFunctional GroupsCodeineMorphineDopamineEpinephrine

章から 5:

article

Now Playing

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

72 閲覧数

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

161 閲覧数

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

210 閲覧数

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

109 閲覧数

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

44 閲覧数

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

152 閲覧数

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

46 閲覧数

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

108 閲覧数

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

142 閲覧数

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

107 閲覧数

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

89 閲覧数

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

120 閲覧数

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

25 閲覧数

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

112 閲覧数

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

71 閲覧数

JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved